We suggested that Glo2 immunostaining could represent a novel additional marker for basal cells in the benign prostate and its absence in malignant cells, consequent to the loss of basal cells, might have been useful as a complement to existing methods to facilitate the pathological diagnosis of PCa. This evidence concerns the gene HAGH and posterior cortical atrophy.